60
Participants
Start Date
August 31, 2025
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
Group F (fentanyl group)
Group F (fentanyl group):will receive intrathecal 1.5 ml hyperbaric bupivacaine 0.5% and 0.5 ml (25 mcg) Fentanyl and 1 ml glucose 5% with total volume of 3ml.
Group D :Dexmedetomidine group
Group D :Dexmedetomidine group: will receive intrathecal 1.5 ml hyperbaric bupivacaine 0.5% and 1 ml (4 mcg) Dexmedetomidine and 0.5 ml glucose 5% with total volume of 3ml.
Group DF :Fentanyl and Dexmedetomidine group
Fentanyl and Dexmedetomidine group:will receive intrathecal 1.5 ml hyperbaric bupivacaine 0.5%, 0.5 ml (25 mcg) Fentanyl and 1 ml (4 mcg) Dexmedetomidine with total volume of 3ml.
Tanta University, Tanta
Tanta University
OTHER